Häftad, Engelska, 2027
Artificial Intelligence in Healthcare
Av Adam Bohr, Kaveh Memarzadeh
2299 kr
Kommande
Finns i fler format
Beskrivning
- Maps real world performance against the hype across drug discovery, oncology, imaging, surgery, medical devices, digital care and insurance
- Covers foundation models, agentic systems and ambient intelligence
- Explains regulatory pathways (FDA, EMA, MHRA, EU AI Act) for AI in medical devices and clinical use, updated for 2025 to 2026
- Addresses security, privacy, ethics, law and liability so AI can be deployed responsibly
Produktinformation
- Utgivningsdatum: 2027-06-01
- Mått: 152 x 229 x undefined mm
- Format: Häftad
- Språk: Engelska
- Antal sidor: 400
- Upplaga: 2
- Förlag: Elsevier Science
- ISBN: 9780443485831
Utforska kategorier
Mer information
Adam Bohr, PhD, holds a doctorate in Biomedical Engineering from University College London and brings over a decade of experience across pharmaceutical sciences, academia, and industry. He currently leads digital transformation initiatives in drug discovery and development at Novo, a global healthcare and pharmaceutical company. He specializes in healthcare AI applications and in addition to his industry role he is the founder and technical lead of Sonohaler, an AI-driven respiratory health company, as well as a co-founder of Zerion Pharma. He co-edited the first edition of Artificial Intelligence in Healthcare and has authored more than 50 peer-reviewed articles. He also lectures in several university courses on AI applications in drug discovery and development at the University of Copenhagen. Kaveh Memarzadeh, PhD, is Director, UK and Ireland, at ChemoMetec, a life science instrumentation company specialising in automated cell counting and analysis. His career combines scientific research with team leadership and the commercialisation of life science technologies. He previously oversaw research management and communications at Orthopaedic Research UK, where he established a funding initiative to help startups develop their ideas and progress towards commercialisation. He holds research affiliations with University College London and Queen Mary University of London, and a PhD in nanotechnology, biomaterials and microbiology. He has published widely in peer-reviewed journals, including work on antimicrobial biomaterials and implant technologies. He co-edited the first edition of Artificial Intelligence in Healthcare (2020).
Butikslager
Ej i lager i butik.
Betyg & recensioner
0 recensioner
Inga recensioner tillgängliga.